TAMSULOSIN HYDROCHLORIDE

Product NDC: 61919-703
Requested package NDC: 61919-703-90
11-digit product format: 619190703
Labeler code: 61919
Product ID: 61919-703_4f5b9312-d5df-2068-e063-6294a90abad0
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: TAMSULOSIN HYDROCHLORIDE
Dosage form: CAPSULE
Route: ORAL
Labeler: Direct_Rx
Application: ANDA202433
Marketing category: ANDA
Marketing start: 2019-07-17
Substance: TAMSULOSIN HYDROCHLORIDE
Active strength: .4 mg/1
Pharmacologic classes: Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 9 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Code, Status table
Captured / source date	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A202433-001	TAMSULOSIN HYDROCHLORIDE	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB		2013-04-30

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A202433-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A202433-001	TAMSULOSIN HYDROCHLORIDE	0.4MG	CAPSULE / ORAL	AB	2013-04-30	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A202433-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202433-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A202433-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202433-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202433-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A202433-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A202433-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A202433-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A202433-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A202433-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A202433-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A202433-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A202433-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A202433-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A202433-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A202433-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A202433-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A202433-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A202433-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A202433-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A202433-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A202433-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A202433-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A202433-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A202433-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A202433-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A202433-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A202433-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A202433-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A202433-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A202433-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A202433-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A202433-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A202433-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A202433-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A202433-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A202433-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A202433-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A202433-001	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A202433-001	AB	1	`cb3db0bc1861…`

Additional Listing Data#

Finished product: Yes
Brand name base: TAMSULOSIN HYDROCHLORIDE
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
TAMSULOSIN HYDROCHLORIDE	.4 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
11SV1951MR	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
863669	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
8de50eca-8cc5-082d-e053-2a95a90a346d	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
ee39297f-c54b-4394-13fa-e0de7b5b9070	Product name	4	20250305
ae349df8-97ce-a639-ed32-50a4cb01b1bd	Product name	4	20200313

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
61919-703-30	2025-01-30	C162847	48780-1	2cef2736-8b98-d83d-e063-dadaa90ab31f	TAMSULOSIN HYDROCHLORIDE
61919-703-30	2025-01-30	C162847	48780-1	2cef2736-8b98-d83d-e063-dadaa90ab31f	TAMSULOSIN HYDROCHLORIDE
61919-703-90	2025-01-30	C162847	48780-1	2cef2736-a607-d83d-e063-dadaa90ab31f	TAMSULOSIN HYDROCHLORIDE

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
61919-703-30	TAMSULOSIN HYDROCHLORIDE	30 in 1 BOTTLE	CAPSULE	30		4
61919-703-90	TAMSULOSIN HYDROCHLORIDE	90 in 1 CAPSULE	CAPSULE	90		2

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
61919-703-30	EA - Each	61919-703	6018d4e7-c182-4eb4-94a3-838b145c4d15	1	2019-08-06
61919-703-90	EA - Each	61919-703	55897a7f-bc84-4f0c-a77b-d8ce72d4ad16	1	2026-05-22

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
61919-703	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECT_RX]	2	Current NDC, Legacy NDC, 1 package rows	20221007_8de50eca-8cc5-082d-e053-2a95a90a346d.zip
61919-703	TAMSULOSIN HYDROCHLORIDE CAPSULE [DIRECT RX]	1	Current NDC, Legacy NDC, 1 package rows	20190119_7a420aca-31e6-8e0c-e053-2a91aa0a1be0.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 32 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	REMEDYREPACK INC.	a608ddc8-fe42-484e-b61f-307c60151138	2026-07-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	REMEDYREPACK INC.	b30e2bde-b20e-4899-a100-f44170d8165b	2026-06-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	Bryant Ranch Prepack	59d0e07c-0018-4681-beb2-cb1c8e2637ee	2026-05-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	St. Marys Medical Park Pharmacy	6142d7b6-e5ea-1af0-e053-2991aa0a00cd	2026-05-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
TAMSULOSIN HYDROCHLORIDE	TAMSULOSIN HYDROCHLORIDE	DIRECT RX	7a420aca-31e6-8e0c-e053-2a91aa0a1be0	2026-04-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433 ndc (package): 61919-703-90 ndc (product): 61919-703 ndc11 (package): 61919070390
TAMSULOSIN HYDROCHLORIDE	TAMSULOSIN HYDROCHLORIDE	Direct_Rx	8de50eca-8cc5-082d-e053-2a95a90a346d	2026-04-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433 ndc (product): 61919-703
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	Bryant Ranch Prepack	fd73ddfd-3773-45b2-9795-9e58744a6803	2026-03-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	Redpharm Drug	4d481f6b-0232-d4af-e063-6394a90ad1af	2026-03-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	PD-Rx Pharmaceuticals, Inc.	f543f5d1-3348-4066-99a4-7a00aee1530d	2026-01-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	Rising Pharma Holdings, Inc.	a242c8dc-576e-4a1f-a9e7-a05d7ebc0e0a	2026-01-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	Northwind Health Company, LLC	d9df4fe0-90ab-0d96-e053-2a95a90a5ff1	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	Cardinal Health 107, LLC	0e3206ba-db3e-40b3-b46b-c7ae4703fdea	2025-10-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	PD-Rx Pharmaceuticals, Inc.	f6b6aeab-bedd-4254-8811-4f65cf8a351f	2025-10-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	A-S Medication Solutions	6a2a4cc7-c88a-4555-a247-d1e63206ffc5	2025-10-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	A-S Medication Solutions	00bb2d71-1f21-494c-aa66-a82be3a0a8e6	2025-10-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	A-S Medication Solutions	1d70b04e-ca08-48d3-937b-eb701b40dd8a	2025-10-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	Preferred Pharmaceuticals, Inc.	82d65964-de00-42c2-baaa-cc3de744b8eb	2025-09-25	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	Major Pharmaceuticals	f8302a6e-b8da-4931-a279-b49e37943816	2025-09-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	Bryant Ranch Prepack	36b8c36f-22e5-40f5-a99a-411115f13df4	2025-05-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433
Tamsulosin Hydrochloride	TAMSULOSIN HYDROCHLORIDE	NuCare Pharmaceuticals,Inc.	cfd48327-a528-58cc-e053-2995a90a129f	2025-02-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202433 application number: ANDA202433

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
11SV1951MR	TAMSULOSIN HYDROCHLORIDE	106463-17-6	TAMSULOSIN HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
863669	tamsulosin HCl 0.4 MG Oral Capsule	PSN	8de50eca-8cc5-082d-e053-2a95a90a346d	4
863669	tamsulosin hydrochloride 0.4 MG Oral Capsule	SCD	8de50eca-8cc5-082d-e053-2a95a90a346d	4
863669	tamsulosin HCl 0.4 MG Modified Release Oral Capsule	SY	8de50eca-8cc5-082d-e053-2a95a90a346d	4
863669	tamsulosin HCl 0.4 MG Oral Capsule	PSN	7a420aca-31e6-8e0c-e053-2a91aa0a1be0	2
863669	tamsulosin hydrochloride 0.4 MG Oral Capsule	SCD	7a420aca-31e6-8e0c-e053-2a91aa0a1be0	2
863669	tamsulosin HCl 0.4 MG Modified Release Oral Capsule	SY	7a420aca-31e6-8e0c-e053-2a91aa0a1be0	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
61919-703-90	61919070390	90 CAPSULE in 1 CAPSULE (61919-703-90)	90 capsule	2018-11-09	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
TAMSULOSIN HYDROCHLORIDE	DIRECT RX	2026-04-22	HUMAN PRESCRIPTION DRUG LABEL	2
TAMSULOSIN HYDROCHLORIDE	Direct_Rx	2026-04-13	HUMAN PRESCRIPTION DRUG LABEL	4